Remdesivir production being doubled to 74.1 lakh per month by May: Dr Harsh Vardhan
Advertisement
New Delhi: Union Health Minister Harsh Vardhan on Sunday said there will be a 10 times rise in Covaxin vaccine production by September while manufacture of remdesivir jabs, an anti-viral drug against Covid-19, will be doubled to 74.1 lakh each month by May.
In a series of tweets, he also said all support is being extended to states to fight Covid-19 and uninterrupted supply of oxygen and enhancement of healthcare infrastructure is being ensured.
Highlighting the steps taken to fulfil the requirement of remdesivir, Vardhan in a tweet said, "Production being doubled to 74.1L per month by May; Express permission given to 20 manufacturing plants to increase production; Exports prohibited; Prices capped; Strict monitoring to curb any malpractice, hoarding and black marketing."
On the issue of oxygen supply, he said in another tweet, "Projected demand of high-burden states mapped with supplies; Oxygen production being maximised and diverted from industrial use to medical use; Expediting installation of 162 PSA plants across the country; Round-the-clock coordination cell assisting the States".
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.